<PAGE>
FORM 8-K
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
April 8, 1998
ROBERTS PHARMACEUTICAL CORPORATION
- --------------------------------------------------------------------------------
(exact name of registrant as specified in its charter)
NEW JERSEY 1-1-432 22-2429994
- ----------------- ---------------- -----------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification
incorporation) Number)
Meridian Center II
4 Industrial Way West
Eatontown, New Jersey 07724
- --------------------------------------------------------------------------------
(Address of principal executive offices, including zip code)
Registrant's telephone number, including area code: 732-389-1182
Meridian Center II
4 Industrial Way West
Eatontown, New Jersey 07724
- --------------------------------------------------------------------------------
(Former name or former address, if changed from last report)
<PAGE>
- 2 -
Item 5. Other Events
------------
Roberts Pharmaceutical Corporation announced today that it has
acquired a US distribution facility located in Buffalo Grove, Illinois just
north of Chicago, from Novartis Pharmaceutical Company. There is an experienced
management and operational staff in place and the Company has begun implementing
its own distribution systems. It is expected that the facility will be fully
operational during 1998.
In the past, Roberts outsourced all its manufacturing and distribution
functions. The Company commented that the acquisition of a distribution center
complements its purchase of a manufacturing facility in July 1997, and given the
Company's existing drug development and sales abilities, Roberts is now well on
track toward becoming a fully integrated pharmaceutical company.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ROBERTS PHARMACEUTICAL CORPORATION
----------------------------------
(Registrant)
Date: April 9, 1998 By: /s/ Anthony A. Rascio
------------------------------
Anthony A. Rascio
Vice President
